TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2015-11-16

Name: TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2015-11-16
Creator: TuHURA BIOSCIENCES, INC./NV

What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2015-11-16 (fiscal Q1 2016): 19 published measures, 41 facts as tagged in accession 0001013762-15-001105.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-16
Fiscal period: fiscal Q1 2016
Accession: 0001013762-15-001105 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.

Reported measures

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	3,545,968	USD
At 2015-06-30	3,396,911	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-514,507	USD
At 2015-06-30	-821,490	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	2,804,096	USD
At 2015-06-30	1,754,433	USD
At 2014-09-30	4,315,746	USD
At 2014-06-30	4,759,711	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,621,388	USD	92
2014-07-01 to 2015-06-30	-4,347,767	USD	365
2014-07-01 to 2014-09-30	-1,516,736	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,401,881	USD	92
2014-07-01 to 2014-09-30	-971,516	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	2,451,544	USD	92
2014-07-01 to 2014-09-30	527,551	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit
At 2015-09-30	-20,236,771	USD
At 2015-06-30	-18,613,294	USD
At 2014-09-30	-15,775,996	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	42,481,875	shares	92
2014-07-01 to 2014-09-30	36,451,014	shares	92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	0.04	USD/shares	92
2014-07-01 to 2014-09-30	0.04	USD/shares	92

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	39,906	USD	92
2014-07-01 to 2014-09-30	48,940	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	3,031,461	USD
At 2015-06-30	2,575,421	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-2,091	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	411,537	USD
At 2015-06-30	853,085	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,077,870	USD	92
2014-07-01 to 2014-09-30	-1,116,627	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-603,845	USD	92
2014-07-01 to 2014-09-30	-671,627	USD	92

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-09-30	21,178	USD
At 2015-06-30	21,178	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,621,388	USD	92
2014-07-01 to 2014-09-30	1,516,736	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-474,025	USD	92
2014-07-01 to 2014-09-30	-445,000	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	543,518	USD	92
2014-07-01 to 2014-09-30	400,109	USD	92

Inspect the source

Entity: TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
Captured: 2026-09-20T09:11:11.339Z
SEC response SHA-256: cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))